United States: CMS Announces Plans To Modernize And Update The Clinical Laboratory Fee Schedule

On November 27, 2013, Centers for Medicare & Medicaid Services posted the final 2014 Medicare physician fee schedule and, in it, announced plans to change how and how much Medicare pays for clinical diagnostic laboratory services under the clinical laboratory fee schedule.


Since 1984, Medicare has paid for most clinical diagnostic laboratory services based on the clinical laboratory fee schedule (CLFS). The CLFS methodology sets Medicare payment rates at the lesser of the amount charged, the fee schedule amount in the state or local geographic area in which the service was performed, or the national limitation amount.

With the exception of modest inflation adjustments, payment rates set under the CLFS do not change. The Centers for Medicare & Medicaid Services (CMS) has established a reconsideration process, whereby the agency can review and adjust newly priced codes; this process does not include an adjustment mechanism for existing codes. As a result, Medicare payments under the CLFS are, essentially, locked in place and unable to adjust based on changes to the cost of the test.

These limits constraining CMS's ability to revisit and revise laboratory service payments have troubled the agency, Congress and the Medicare Payment Advisory Commission for years and led all three, at various times, to recommend and pursue various changes that afford the agency more flexibility.

In the final 2014 physician fee schedule (PFS), CMS announced a bold step toward exerting more discretion. CMS announced a process whereby it will systematically examine payment amounts under the CLFS. This examination would seek to identify codes that had undergone technological changes affecting the price of the test. CMS cites the increased use of point-of-care testing, genetic and genomic testing, and laboratory-developed tests as examples of instances in which technological change may have created a disconnect between the current market value for the test and the Medicare payment rate and as the rationale for developing and finalizing this process.

CMS's final policy continues to define a technological change as: any change to the tools, machines, supplies, labor, instruments, skills, techniques and devices that result in changes to the resources required to perform the test; the types of personnel required to perform the test; and/or the volume, frequency and site of service of the testing.

CMS's final policy does not address the impact of any nontechnology-based costs, such as intellectual property costs, that can substantially add to the overall costs of certain newer tests and which are generally not accounted for in CLFS payment rates.

Under the new process, CMS will review all CLFS codes during a five-year period (beginning with the oldest codes), review a portion of the total codes each year and make appropriate adjustments. CMS intends to use data from any source in order to determine the accurate cost for laboratory services.

In a change from their proposal, CMS will allow public nomination of codes for evaluation at any time, as opposed to only after the initial five-year review of all codes is completed. The public may nominate codes for review by providing CMS an explanation of the changes in technology affecting the cost of the service and by providing relevant cost information to support the nomination. This will allow the public more immediate participation in the update process; however, CMS will require public nominations to include cost information. This could have the effect of limiting the population from whom nominations can be submitted to only the laboratories most closely associated with either producing or performing the tests.

CMS rejected comments calling for a process that mirrored the negotiated rulemaking process and those calling for the creation of an expert advisory panel. CMS believes that the level of transparency and public input associated with the formal PFS annual rulemaking process would serve the same purpose as other processes, without the time-consuming and resource-intensive requirements.

The first review period will begin prior to the July, 2014, publication of the 2015 PFS notice of proposed rulemaking (NPRM). CMS will spend the early part of 2014 identifying which codes should be included in this first phase of adjustments, evaluating those codes and determining appropriate payment adjustments. CMS will publish its list of codes subject to payment adjustment, along with a discussion of the impact of changes to technology and the proposed payment adjustment in the 2015 PFS NPRM. CMS will solicit comments on the codes proposed for adjustment as well as solicit additional codes for adjustment in a subsequent year. CMS will finalize payment adjustments in the 2015 PFS final rule, in early November, 2014. Final payment adjustments will be effective beginning January 1, 2015.

In 2015 and subsequent years, the cycle will repeat, with the addition of the codes nominated in the previous year's cycle for which CMS believes that information warrants price adjustment.

CMS did not elaborate on the process it will use to evaluate codes for possible adjustment nor did it indicate its intention to perform the evaluation in-house or to outsource the evaluation. CMS also did not indicate whether it would allow subsequent reconsideration of price adjustments using a process similar to the existing reconsideration process for newly priced codes.

Interested stakeholders should review CMS' final rule in the broader context of the evolving reimbursement landscape for clinical laboratory services.

John Warren is the Senior Director for Health Policy at McDermott Will & Emery.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions